Comment on Paolisso et al. Impact of Admission Hyperglycemia on Heart Failure Events and Mortality in Patients With Takotsubo Syndrome at Long-term Follow-up: Data From HIGH-GLUCOTAKO Investigators. Diabetes Care 2021;44:2158–2161

John E. Madias
DOI: https://doi.org/10.2337/dc21-1542
2021-10-18
Diabetes Care
Abstract:I read with interest the contribution by Paolisso et al. (1) about the performance of admission hyperglycemia (AH) (blood glucose >140 mg/dL) as a predictor of long-term prognosis in 76 patients with takotsubo syndrome (TTS), 28 with and 48 without AH. Patients with AH showed lower left ventricular ejection fraction on admission and discharge and higher levels of B-type natriuretic peptide and inflammatory markers, with the glucose values correlating with serum norepinephrine levels. In a subgroup of 30 patients who underwent a 123I-MIBG cardiac scintigraphy, patients with AH showed lower late heart-to-mediastinum ratio values at a follow-up of 12 and 24 months than the ones without AH. Patients with AH had higher rates of heart failure and all-cause mortality after 24 months than the ones without AH, with tumor necrosis factor-α and serum norepinephrine being independent predictors of heart failure.
endocrinology & metabolism
What problem does this paper attempt to address?